Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Valliant John Create: Alert

All | News | Filings
Date FiledTypeDescription
01/09/2023 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 500,000 options to buy @ $3.75, valued at $1.9M
04/27/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 2,036 shares @ $6.03, valued at $12.3k
Sold 2,147 shares @ $6.07, valued at $13k
Sold 4,511 shares @ $6.03, valued at $27.2k
04/22/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 367 shares @ $6.02, valued at $2.2k
Sold 922 shares @ $6.01, valued at $5.5k
04/13/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 2,600 shares @ $7.37, valued at $19.2k
Sold 18,255 shares @ $7.1, valued at $129.6k
Sold 11,994 shares @ $6.41, valued at $76.9k
04/08/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 100 shares @ $7.58, valued at $758
Sold 1,255 shares @ $7.56, valued at $9.5k
Sold 826 shares @ $7.52, valued at $6.2k
04/05/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 1,000 shares @ $7.75, valued at $7.8k
Sold 700 shares @ $7.81, valued at $5.5k
Sold 2,100 shares @ $7.67, valued at $16.1k
04/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 500 shares @ $7.42, valued at $3.7k
Sold 9,600 shares @ $7.55, valued at $72.5k
Sold 200 shares @ $7.52, valued at $1.5k
03/24/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 4,000 shares @ $7.53, valued at $30.1k
Sold 100 shares @ $7.5, valued at $750
Sold 700 shares @ $7.46, valued at $5.2k
03/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 12,600 shares @ $8.33, valued at $105k
Sold 33,202 shares @ $7.99, valued at $265.3k
Sold 1,700 shares @ $7.98, valued at $13.6k
02/08/2021 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 336,000 options to buy @ $11.9, valued at $4M
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy